Navigation Links
BL21 Star (DE3) One Shot Chemically Competent E. coli from Invitrogen

ProductsBL21 Star (DE3) One Shot Chemically Competent E. coli from Invitrogen
Company Invitrogen
Item BL21 Star (DE3) One Shot Chemically Competent E. coli
Price 
Description BL21 Star strains are high-performance BL21 hosts designed for improved protein yield in T7 promoter-based expression systems (Figure 1). Because the T7 RNA polymerase synthesizes mRNA more rapidly than E. coli RNA polymerases transcription from the T7 p
Info InvitrogenInvitrogen
Invitrogen Corporation
1600 Faraday Ave.
Carlsbad, CA 92008

Call Invitrogen to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-521-4270
Customer Service: 800-955-6288
Tech Support: 800-955-6288 ext. 2
Fax Number: 760-603-7229
Web Site: http://www.invitrogen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Origami(DE3)pLysS Glycerol Stock from Novagen
2. Origami(DE3) Glycerol Stock from Novagen
3. Zero Blunt TOPO PCR Cloning Kit with One Shot TOP10 Chemically Competent E. coli from Invitrogen
4. Zero Blunt TOPO Kit for Sequencing with One Shot Mach1 T1 Phage-Resistant Chemically Competent E. coli from Invitrogen
5. Zero Blunt TOPO PCR Cloning Kit with One Shot Mach1 T1 Phage-Resistant Chemically Competent E. coli from Invitrogen
6. GIBCO Chemically Defined Lipid Concentrate from Invitrogen
7. One Shot INVAlphaF Chemically Competent E. coli from Invitrogen
8. CopyControl cDNA, Gene and PCR Cloning Kit w/ Chemically Competent E. coli cells from EPICENTRE Biotechnologies
9. pET GST Fusion System 42 plus Competent Cells from Novagen
10. pET GST Fusion System 41 plus Competent Cells from Novagen
11. BL21 Competent Cell Set* from Novagen
HP Guaranteed siRNA from QIAGEN
...ells are used for heterologous protein expression ...S2 cell line was derived from a primary culture of...ster embryos (1). This versatile cell line grows...sily adapted to suspension culture. S2 cells are ...
...ression vectors, we in-troduced a new concept, nam...) at tran-scriptional level at the T7 phage promot...fying the plasmid copy number, The main advantage ... retains practically all of the outstanding featur...
...or NTI allows you to store and manage very large a...al relational database. Storing and managing data ...ne tracking and enables you to locate your data ea...egrates seamlessly with Invitrogen's desktop seque...
Biology Products:
(Date:11/8/2009)...TTE, Ind. - Researchers at Purdue University have ...rve fibers in spinal cord injuries using nano-sphe...after an accident. , The synthetic "copolymer mi...ers in diameter, or roughly 100 times smaller than... have been studying how to deliver drugs for cance...
(Date:11/6/2009)...gistration is now open for the Society of Interven...cology (IO) Therapies" Webinar, which will provide...ter treatment of liver tumors, kidney tumor ablati...nization of physicians, scientists and allied heal...lth through pioneering advances in image-guided th...
(Date:11/6/2009)...ov. 6 Auburn Hills, MI-based Law E... installing its locker system and patent-pending B....S. Department of Health and Human Services, Natio...MD. The locker system will support the NIH,s enti... our nation,s medical research agency. The projec...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2CardioFocus Receives CE Mark for Atrial Fibrillation Ablation Catheter 50857 1CardioFocus Receives CE Mark for Atrial Fibrillation Ablation Catheter 50857 2Burnham Institute for Medical Research and Magellan BioScience Group Inc Announce Drug Discovery Collaboration 12905 1Burnham Institute for Medical Research and Magellan BioScience Group Inc Announce Drug Discovery Collaboration 12905 2Burnham Institute for Medical Research and Magellan BioScience Group Inc Announce Drug Discovery Collaboration 12905 3Symon Announces Revolutionary New Application InView Mobile 26amp 3B 238482 3B 50851 1Symon Announces Revolutionary New Application InView Mobile 26amp 3B 238482 3B 50851 2Symon Announces Revolutionary New Application InView Mobile 26amp 3B 238482 3B 50851 3
...n the cell can serve as an advanced tool for mappi...technique in which non-invasive magnetic resonance... results of this research, conducted by Prof. Mich...egulation Department, were published in the resear...Batya Cohen of the Institute,s Molecular Genetics ...
...Hopkins show that stem cell therapy can be used ef...farction, in pigs. In just two months, stem cells ...ted into the animal,s damaged heart restored heart...percent to 75 percent. , The Hopkins findings, fir...ions of the American Heart Association, are to be ...
... relative excavated last year at Petrified Forest ...ries of how and where the dinosaurs arose more tha... Period. , The animal, one of many creatures from...s thought to be an ancestor of the plant-eating or...tops, which roamed the world millions of years lat...
Other Biology News:Novel live reporting system to track cells 2Stem cell therapy successfully treats heart attack in animals 2Agilent Technologies introduces high-capacity human protein removal system for proteomics research 2Agilent Technologies introduces high-capacity human protein removal system for proteomics research 3Agilent Technologies introduces high-capacity human protein removal system for proteomics research 4
(Date:11/6/2009).... 6 ,, 3Q09 Corpor...enza(TM) E.U. Marketing Authorization to Astellas ...commercial readiness activities Expanded manageme...eting; and Director, Commercial Operations Appoin...udit Committee chairman , Upcoming 2009 Mil...
(Date:11/6/2009)...6 Intarcia Therapeutics, Inc. deli...OS® continuous delivery of exenatide) program... Annual Diabetes Technology Meeting in San Francis...in/prnh/20050301/SFTU126LOGO ) ,, Continuous ...wers Plasma Glucose, HbA1c and Reduces Weight in a...
(Date:11/5/2009).... 5 GenVec, Inc. (Nasdaq...r the third quarter ended September 30, 2009. GenV...share) for the three months ended September 30, 20...er share) in the comparable quarter of 2008. For t...net loss was $14.1 million ($0.15 per share), comp...
(Date:11/5/2009)...ewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bullet...cer, President and CEO of Imagenetix, will be pres...CRO Conference on Thursday, December 3rd, at 10:30...bout LD MICRO ,, LD MICRO is a by-invitation on...lued companies in the micro-cap space. Since 2002,...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2